Integrating Hepatitis C Screening With Dried Blood Spot Testing Into Colorectal Cancer Screening
Clinical Trial to Evaluate the Acceptance and Viability of Three Strategies in Birth Cohort Hepatitis C Screening
1 other identifier
interventional
609
1 country
1
Brief Summary
The main purpose of the study is to compare the acceptance and viability of three strategies aimed to screen hepatitis C virus (HCV) infection in a birth cohort by: a) invitation letter offering HCV screening with dried blood spot (DBS) testing at the primary care center, b) invitation letter offering both HCV and colorectal cancer (CCR) screening with faecal occult test (FOT) at the primary care center, and c) invitation letter offering self-collected screening at home for HCV and CCR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedFirst Submitted
Initial submission to the registry
July 23, 2019
CompletedFirst Posted
Study publicly available on registry
July 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedApril 30, 2021
April 1, 2021
8 months
July 23, 2019
April 28, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Acceptance of the interventions
overall screening rate (number of subjects participating after enrollment)
12 months
Secondary Outcomes (3)
Feasibility of the intervention measuring quality of spotted cards
12 months
Subject characteristics associated with participation and feasibility of the different strategies
12 months
Effectiveness of each strategy: rate of HCV positivity
12 months
Study Arms (3)
Screening HCV with DBS at primary care centers
EXPERIMENTALPatients assigned to the strategy 1 will receive an invitation letter for HCV screening with DBS at the primary care center to be performed by the general practitioner
Screening HCV and CCR with FOT at primary care centers
ACTIVE COMPARATORPatients assigned to the strategy 2 will receive an invitation letter for HCV screening with DBS and CCR screening with FOT at the primary care center to be performed by the general practitioner
Self-testing at home for screening HCV and CCR
ACTIVE COMPARATORPatients assigned to the strategy 3 will receive an invitation letter for self-testing at home for HCV screening with DBS, and CCR screening with FOT
Interventions
Patients assigned to this strategy will receive an invitation letter for HCV screening with DBS and CCR screening with FOT at the primary care center to be performed by the general practitioner
Patients assigned to this strategy will receive an invitation letter for self-testing for HCV screening with DBS, and CCR screening with FOT
DBS for HCV screening at primary care center
Eligibility Criteria
You may qualify if:
- Age 50-70 years
- Subjects attending selected primary care centers
- Willing to participate (informed consent signed)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Manuel Hernandez-Guerra, MD
San Cristóbal de La Laguna, Santa Cruz De Tenerife, 38320, Spain
Related Publications (3)
Buti M, Dominguez-Hernandez R, Casado MA, Sabater E, Esteban R. Healthcare value of implementing hepatitis C screening in the adult general population in Spain. PLoS One. 2018 Nov 28;13(11):e0208036. doi: 10.1371/journal.pone.0208036. eCollection 2018.
PMID: 30485377BACKGROUNDZuure FR, Urbanus AT, Langendam MW, Helsper CW, van den Berg CH, Davidovich U, Prins M. Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review. BMC Public Health. 2014 Jan 22;14:66. doi: 10.1186/1471-2458-14-66.
PMID: 24450797BACKGROUNDTuaillon E, Mondain AM, Meroueh F, Ottomani L, Picot MC, Nagot N, Van de Perre P, Ducos J. Dried blood spot for hepatitis C virus serology and molecular testing. Hepatology. 2010 Mar;51(3):752-8. doi: 10.1002/hep.23407.
PMID: 20043287BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manuel Hernandez-Guerra, MD
MD
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 23, 2019
First Posted
July 30, 2019
Study Start
March 1, 2019
Primary Completion
November 1, 2019
Study Completion
November 1, 2019
Last Updated
April 30, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share